ASHTON VIEW MEDICAL CTR
7 ASHTON VIEW, LEEDS
CKD 4
The percentage of patients on the CKD register with hypertension who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 19 | 19 | 100.0% | |
| CKD 4 | 2008 | 36 | 47 | 76.6% | |
| CKD 5 | 2009 | 8 | 10 | 80.0% | |
| CKD 5 | 2010 | 3 | 3 | 100.0% | |
| CKD 5 | 2011 | 4 | 4 | 100.0% | |
| CKD 5 | 2012 | 5 | 5 | 100.0% | |
| CKD 5 | 2013 | 5 | 5 | 100.0% | |
| CKD003 | 2014 | 3 | 3 | 100.0% | |
| CKD003 | 2015 | 4 | 4 | 100.0% | |
| NM84 | 2016 | 4 | 4 | 100.0% | |
| NM84 | 2017 | 4 | 4 | 100.0% | |
| NM84 | 2018 | 4 | 4 | 100.0% | |
| NM84 | 2019 | 4 | 6 | 66.7% | |
| NM84 | 2022 | 3 | 5 | 60.0% | |
| NM84 | 2023 | 3 | 4 | 75.0% |
